West Chester-based Aqua Pharmaceuticals today announces the addition of Brett Fair as Vice President of Corporate Development. In this role Fair will be responsible for initiation and execution of transactions that will bring new products and development opportunities to the Aqua portfolio.
“This role in particular requires someone with an in-depth understanding of the dermatology market and solid relationships within the specialty” said Chief Operating Officer Ted White. “We found that dynamic combination in Brett. I have no doubt that his considerable knowledge and expertise will yield tremendous value and opportunity in the evolution of Aqua.”
With more than 15 years of pharmaceutical experience Fair has a significant background in both the U.S. and international dermatology specialty. Prior to joining Aqua he served as Global Commercial Lead at Stiefel a GSK company. He joined Stiefel in 2010 as Director of Business Development and Licensing and was responsible for identifying opportunities to drive growth and address strategic gaps in the Stiefel global product portfolio. Fair’s notable pharmaceutical career also includes roles at Graceway Pharmaceuticals LLC and Allergan Inc.
“Brett has a proven track record in dermatology sales and marketing and multiple awards for commercial excellence” White said. “We are so happy to have him join our team.”
Fair received his undergraduate degree from the University of Delaware and his graduate degree from the Graziadio School at Pepperdine University. He also completed the Medical Marketing Program at The Anderson School at UCLA.
About Aqua Pharmaceuticals
West Chester Pennsylvania-based Aqua Pharmaceuticals is a rapidly growing specialty pharmaceuticals company focusing on acquiring developing and marketing prescription dermatology products. Aqua is a portfolio company of RoundTable Healthcare Partners an operations-oriented private equity firm. For more information visit www.aquapharm.com.Business Wire
Last updated on: 25/07/2013